Geary Richard S

ISIS Pharmaceuticals Inc.

EVP, Chief Development Officer

Avg. Two Year Performance

No Purchase Track Record

(29%) Avg. Sale Return (14%) Compound

Holdings: 84.83K shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drug Manufacturers - Other

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions